Product Code: RP-ID-10325363 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10325363
Market Overview:
Biopsy Devices Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2016 - 2025
Global Biopsy Devices Market is estimated to reach $2,894 million by 2025; growing at a CAGR of 6.2% from 2017 to 2025. A biopsy is a medical test, mainly used to detect cancer, performed by surgeons, cardiologist or by radiologist. It involves in the extraction of sample cells or tissues for examination to determine the presence of diseases. A biopsy can be used to investigate the abnormalities which can be functional, such as kidney and liver problems or structural, such as swelling in a particular organ. Biopsy of any cell or organ is to diagnose the abnormalities as benign or malignant. There are two main types of biopsies, needle and surgical biopsy.
Increasing number of incidences of cancer such as breast, prostate and lung is stimulating the growth of world biopsy market. Moreover, increasing demand for minimal invasion surgeries, rapid technological advancements and increasing awareness for diagnosis is also expected to elevate the market. However, high cost of biopsy devices and stringent regulations and standards for the use of biopsy and increasing complaints of breast cancer screening procedures are impeding the growth of the market. Moreover, increasing public awareness about chronic diseases in developing countries and need for disease screening for their early diagnosis and treatment provides opportunity for the growth of the market.
The market is segmented on the basis of device type, imaging technology, application, end-user and geography. Based on device type, the market is segmented into breast, gastrointestinal, bronchial, gynaecological, robotic, soft tissue, and other device types. CT scan, ultrasound-guided biopsy, MRI-guided biopsy, stereotactic-guided biopsy, and other imaging technologies are the bifurcations of imaging technology. By application, the market is segregated into breast biopsy, lung, prostate, liver, gastrointestinal, kidney, gynaecological, and other applications. Furthermore, hospital, and diagnostic centers are covered under end-user segment.
Based on geography, the global biopsy devices market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is further bifurcated in U.S., Canada, and Mexica, whereas Europe consists of UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific while RoW is bifurcated into South America, Middle East, and Africa.
Some of the major companies in global biopsy devices market include Boston Scientific Corporation, Carefusion, Becton, Dickinson and Company, Olympus Corporation, Devicor Medical Products Inc., B. Braun Melsungen AG, FUJIFILM Holdings Corporation, Angiotech, Cardinal Health Inc., and INRAD, Inc., among others.
The key takeaways from the report
The report will provide detailed analysis of Global Biopsy devices market with respect to major segments such as device type, imaging technology, application and end user of the market.
The report will include the qualitative and quantitative analysis with market estimation over 2016 - 2025 and compound annual growth rate (CAGR) between 2017 and 2025
Comprehensive analysis of market dynamics including factors and opportunities has been included in the report
An exhaustive regional analysis of Global Biopsy devices market has been covered under the scope of the report
Profile of key players of the Global Biopsy devices market, which include key financials, product & services and new developments
Scope of Global Biopsy Devices Market
Device Type Segments
Breast
Gastrointestinal
Bronchial
Gynaecological
Robotic
Soft tissue
Other Device Types
Imaging Technology
CT scan
Ultrasound-Guided Biopsy
MRI-guided biopsy
Stereotactic-Guided Biopsy
Other Imaging Technologies
Application Segments
Breast Biopsy
Lung
Prostate
Liver
Gastrointestinal
Kidney
Gynaecological
Other Applications
End-User Segments
Hospitals
Diagnostics Centers
Geographical Segments
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
RoW
South America
Middle East
Africa
Related Reports
Proof of Quality & Reliability
